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Among lung cancers, a substantial shift over time has occurred in the recorded frequency of adenocarci-
noma (AdC) relative to that of squamous cell carcinoma (SqCC). This is evident in many countries, and also
in those who have never smoked. We attempted to address the extent to which this increase is real, or an
artefact of changing diagnostic practices. We reviewed studies re-evaluating diagnoses using more up-to-
date criteria, and studies applying standard criteria to cases collected over a long period. We also describe
changes to classiﬁcations, and factors affecting diagnostic accuracy and consistency. While the four main
types have long remained essentially unchanged, successiveWHO classiﬁcations differ in how tumours are
ascribed to these types. Despite reﬁnement of classiﬁcations and technological advances, the decision is
ultimately the pathologist's. In 11 studies, 189/1212(15.6%) originally diagnosed AdCs were reclassiﬁed as
non-AdC on review, whereas 541/1564(34.6%) of non-AdCs were reclassiﬁed as AdC, increasing AdCs by
30%. Studies examining trends in the proportion of AdC were conﬂicting; three showing a declining trend,
seven no trend, and six some increase. Some studies ﬁnd lepidic (bronchioloalveolar) carcinoma, but not
other AdC sub-types, increased. The rising AdC/SqCC ratio results at least partly from diagnostic changes.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction1
Over at least the last 40 years there has been a substantial shift
in many countries in the reported frequency of adenocarcinoma
(AdC) of the lung relative to that of squamous cell carcinoma (SqCC)
(Burns, 2014; Charloux et al., 1997; Devesa et al., 2005; US Surgeon
General, 2014). This increase is evident both in smokers (US
Surgeon General, 2014) and in those who have never smoked
(Lee and Forey, 2013; Lee et al., 2016a).
In this paper, we attempt to address the extent to which this
increase is a real one, or is an artefact of changing diagnostic
practices. Our review is divided into four sections. The ﬁrst two
sections are descriptive, section 3.1 summarizing the various
schemes used over the years to classify histological types of lung
cancer, and section 3.2 discussing difﬁculties in implementingmputing Ltd, 17 Cedar Road,
Lee), J.Gosney@rlbuht.nhs.uk
carcinoma; LgCC, large cell
mous cell carcinoma; WHO,
Inc. This is an open access article uthese. The ﬁnal two sections provide more direct evidence. Section
3.3 summarizes evidence from studies that have re-evaluated di-
agnoses made earlier, to give insight into the magnitude of effects
caused by diagnostic change. In section 3.4 we consider studies
examining time trends directly by applying standard classiﬁcation
criteria to slides from lung cancer cases that have been collected
over 10 or more years, so gaining insight into any true change in the
distribution of histological type.
Except for section 3.2, publications are generally considered
chronologically, so the reader sees the evidence building up over
time, with conclusions summarized at the end. Few publications
separate out results for smokers and nonsmokers, but relevant
ﬁndings are mentioned where they do.
In the discussion section we also consider claims recently made
(US Surgeon General, 2014) that the increase in the observed AdC/
SqCC ratio is due to changes in the design and composition of
cigarettes since the 1950s and is not due to changes in tumour
classiﬁcation and diagnosis.2. Methods
Sources of publications included in-house ﬁles on lung cancernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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bequeathed to PNL by the late Dr. F.J.C. Roe), papers relating to all
epidemiological studies of over 100 cases on smoking and lung
cancer published before 2000 (Lee et al., 2012) andmany published
since (Fry et al., 2013), and papers relating to a meta-analysis on
environmental tobacco smoke and lung cancer (Lee et al., 2016b).
Relevant secondary references are also considered. While section
3.1 (classiﬁcation of lung cancer type) and section 3.2 (accuracy and
consistency of diagnosis of type) are not intended to be compre-
hensive, section 3.3 (re-evaluation of earlier diagnoses) and section
3.4 (time changes in histological type using standard diagnostic
criteria) describe all relevant studies found.
For section 3.3 we aimed to extract data from studies providing
data on the two-way distribution of lung cancer type (SqCC, AdC,
other) based on initial diagnosis and on a review based on standard
criteria (or on diagnosis according to two differing classiﬁcation
schemes). Where the breakdown givenwas more detailed, the data
were collapsed to the required 3  3 table, with BalC combined
with AdC, for consistency with other studies. From the table, we
calculated the distribution by type separately for initial diagnosis
and review, the numbers of cases transferring into and out of AdC
with signiﬁcance of the ratio estimated using the McNemar test
(Conover, 1999), and the ratio of the relative frequency of AdC to
SqCC following review to that determined initially.
Section 3.4 limits attention to studies covering at least 10 years.
Results are presented for each study, giving, for successive time
periods, subdivided where possible by sex, numbers of cases
studied and the distribution by broad categories of type. Usually
this is for the same groups as before, though where available
separate results are shown for BalC. Results of tests of trend over
time period (Armitage, 1955) in the reported proportion of lung
cancers which are AdC, SqCC, BalC or AdC-BalC are shown for each
study/sex combination, where data permit. For both sections 3.3
and 3.4, the reader is referred to the source papers for any more
detailed breakdown by type.
3. Results
3.1. Classiﬁcation of lung cancer type
The morphological classiﬁcation of lung cancer based on its
microscopic characteristics formulated early in the 1900s has
changed little in general structure over almost 100 years. The
gradual realisation that the so-called ‘oat-celled sarcoma of the
mediastinum’was actually a primary lung tumourmasquerading as
a mediastinal lymphoma because of its early dissemination into
regional lymph nodes, led, in the early 1920s, to the recognition of
four basic types (Marchesani, 1924). These were Basalzellenkrebse
basal cell carcinoma; equivalent to small cell carcinoma (SmCC) in
current terminology), Polymorphzellige Krebse (polymorphocellular
carcinoma, equivalent to large cell carcinoma (LgCC), Verhornende
Plattenepithelkrebse (equivalent to SqCC) and Zylinderzellige Ade-
nokarzinome (cylindrical cell carcinoma, equivalent to AdC).
Although subsequently-recognised variants such as BalC did not ﬁt
neatly into these categories, Marchesani's classiﬁcation stood the
test of time so well that, when Kreyberg et al. formulated the ﬁrst
classiﬁcation under the auspices of the World Health Organization
(WHO) in the late 1950s and 1960s (Kreyberg, 1967a), it was
acknowledged as being ‘so comprehensive and logical that it
remained substantially unchanged for some 25 years’.
The ﬁrst WHO classiﬁcation of lung cancer was formulated by
the International Reference Centre for the Histological Deﬁnition and
Classiﬁcation of Lung Tumours established in 1958. Meetings of
contributors in 1958 and 1964 were followed by its eventual pub-
lication in 1967 (Kreyberg, 1967a). Marchesani's earlierclassiﬁcation was recapitulated almost exactly in the categories
epidermoid carcinoma, small cell anaplastic carcinoma, adenocarci-
noma and large cell carcinoma, to which were added combined
carcinomas, bronchial gland tumours, mixed tumours and sarcomas. A
category of unclassiﬁed tumours was recognised as were mesothe-
liomas; melanomas were considered a ﬁnal, separate group.
The 1981 revision of the ﬁrst, 1967, WHO classiﬁcation, actually
published in 1982 (World Health Organization, 1982), changed lit-
tle, certainly regarding the four major categories, although the
separation of carcinoid tumours from those arising from bronchial
glands presaged their recognition as tumours characterised by
neuroendocrine differentiation and related in this aspect of their
biology to SmCC. Notably, however, certain tumours classiﬁed as
LgCC in the 1967 classiﬁcation would, in the 1981 classiﬁcation, be
categorised as AdCs with a solid growth pattern.
The next revision of theWHO classiﬁcation took almost 20 years
to emerge (Travis et al., 1999). Although its structure remained
essentially unchanged, the number of categories and subcategories
increased signiﬁcantly, with pre-invasive proliferations now
included. Importantly, AdCs were sub-classiﬁed with bronchio-
loalveolar carcinoma as one of these subcategories. The 2004 WHO
classiﬁcation is essentially a minor revision of the 1999 scheme and
did not differ signiﬁcantly from it (Beasley et al., 2005).
Over the past decade, major shifts in the classiﬁcation of lung
cancer continue to be in the emerging recognition of sub-types of
AdC, particularly early pre-invasive and minimally invasive vari-
ants. Accordingly, a new classiﬁcation of AdCwas formulated by the
International Association for the Study of Lung Cancer, the Amer-
ican Thoracic Society and the European Respiratory Society (Travis
et al., 2013) and has recently been incorporated into the 2015WHO
classiﬁcation (Travis et al., 2015).
Particularly signiﬁcant in this latest scheme is that tumours
previously categorised as LgCC, but which express antigens char-
acteristic of pneumocytic differentiation, would now be classiﬁed
as AdCs.
A further factor inﬂuencing lung cancer classiﬁcation more
recently is the use of immunochemistry to aid distinction between
tumour types. Because detection in cells or tissue sections of anti-
gens closely allied to the different types of lung cancer can aid
distinction, its routine use has been driven by the pressing need for
more accurate classiﬁcation as a prerequisite for genomic proﬁling
(Cagle et al., 2011). The welcome reduction in the proportion of
lung cancers classiﬁed merely as ‘non-small cell carcinoma, not
otherwise speciﬁed’ (Rich et al., 2011) has inevitably increased the
proportion given a more precise diagnosis, shifting many such tu-
mours into the AdC category.
3.2. Accuracy and consistency of diagnosis
In their early study of smoking and lung cancer, Wynder and
Graham (1950) were struck by the variation between pathologists
morphologically classifying lung cancer specimens, noting that
’what some pathologists would designate as an AdC, others would
classify as an undifferentiated carcinoma.' Variability within and
between pathologists has been evident repeatedly in numerous
studies since.
In a seminal early study, for example, Feinstein et al. (1970)
studied intra- and inter-observer variability in classifying lung
cancer between ﬁve experienced pathologists independently
studying 50 specimens on two occasions. Unsurprisingly, the
greatest discrepancy related to distinguishing poorly differentiated
squamous (epidermoid) from AdC, where it reached 42%. Signiﬁ-
cant disagreement between the two readings of the same slide by
the same pathologist was as high as 20%. In another study (Weiss
et al., 1970), of 161 specimens of lung cancer, unanimity between
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Despite increasingly well-deﬁned systems of classiﬁcation and
guidelines emerging to assist pathologists, and their constant
revision, discrepancies in classiﬁcation have persisted (Auerbach
et al., 1975; Cane et al., 2015; Roggli et al., 1985).
Part of the problem resides in the notorious morphological
heterogeneity of lung carcinoma rendering interpretation of mul-
tiple large sections from resected tumours (Roggli et al., 1985) or
tumours sampled post mortem (Auerbach et al., 1975) particularly
challenging. It is not unusual for elements of all major morpho-
logical types to be present in the same tumour and, occasionally,
even in a single tissue block.
Even when smaller biopsy specimens are assessed, so consid-
erably reducing the confounding factor of morphological vari-
ability, discrepancies nevertheless remain common (Thomas et al.,
1993). In a recent survey of lung cancer units across England, where
all pathology reports on specimens taken for diagnosis of suspected
lung cancer over a six month period were scrutinised (Cane et al.,
2015), the proportion of tumours classiﬁed as AdC ranged from
25 to 60% with corresponding variability in those classiﬁed as SqCC,
SmCC, or as ‘non-small cell, not otherwise speciﬁed’.
It is clear also that the morphological type of tumour is inﬂu-
enced by its site within the lung and how a specimen is obtained;
whether by bronchial endoscopy or transthoracic needle biopsy,
and whether it comprises dispersed cells (‘cytology’) or tissue
(‘histology’). Thus, SqCC, more often arising in central airways than
in the lung periphery. Is likelier to be represented in endoscopic
bronchial biopsies and bronchial washings or brushings than in
transthoracic needle biopsies, with the converse true for AdC. For
the same reason, AdC is more often represented in surgical resec-
tion specimens, because the generally more central SqCC is less
often amenable to surgical resection, and because surgery is not
conventionally the treatment of choice for SmCC, presumed to be
disseminated in most cases even at diagnosis and for which the
most appropriate management is chemotherapy. AdC tends to
predominate in tumours sampled post mortem (Law et al., 1976).
In summary, this section underlines some of the difﬁculties
involved in accurately and consistently classifying lung cancer by
morphological criteria, latterly supplemented by immunochem-
istry, and it is sobering that two studies 45 years apart (Cane et al.,
2015; Feinstein et al., 1970) show little has changed. Classiﬁcations
have been reﬁned and guidelines introduced and revised as
knowledge and technology have advanced, but the decision made
by the pathologist remains essentially one of subjective
interpretation.
3.3. Re-evaluation of earlier diagnoses of histological type
Ten studies reviewed diagnoses of histological type made some
years earlier, and provided a breakdown of cell type according to
the two sources (Table 1).
In a study in Philadelphia, USA, 179 men developed conﬁrmed
lung cancer in 1951e60. Weiss et al. (1970) described a re-
examination of slides for 161 cases by three pathologists using a
modiﬁed WHO 1967 classiﬁcation (Yesner et al., 1965). There were
37 discrepancies, but little change in the reported proportion of
AdC.
Yesner et al. (1973) described a study in Connecticut, USA, where
the histological type of 449 cases assigned in 1953e59 was re-
evaluated in 1967e69 by one pathologist, using a modiﬁed WHO
1967 classiﬁcation (Yesner et al., 1965). Although 17 AdC cases were
unconﬁrmed on review, 68 new cases were diagnosed, increasing
the percentage from 17.8% to 29.2%. In 33 never smokers, the
number of AdCs rose on review from 18 to 20 and of epidermoid
cases fell from 8 to 2.Vincent et al. (1977a; 1977b) described a study in Buffalo, USA,
with slides from 289 patients assessed in 1962e68 re-evaluated by
one pathologist using a modiﬁed WHO 1967 classiﬁcation
(Matthews, 1973). 29 cases were transferred to AdC (including
BalC), as against 10 transferred fromAdC, increasing the percentage
from 11.4% to 18.0%. With BalC not included in AdC, the percentage
increased from 8.7% to 17.0%. The authors note “While the effects of
changes in criteria for reading pathology slides accounts for some
of the observed increase in AdC, a substantial additional increase
not accounted for by changes in histopathological reading is still
present”.
Greenberg et al. (1984) described a study in NewHampshire and
Vermont, USA involving 1906 cases diagnosed in 1973e76. Slides
were obtained for 1,179, one author reviewing histological type
using the WHO 1967 classiﬁcation (Kreyberg, 1967a). The review
transferred 115 cases to AdC and 48 fromAdC, the percentage rising
from 14.1% to 19.8%. The authors note that “the diagnosis made by
the original pathologist was generally conﬁrmed upon review,
except for the large cell undifferentiated cell type which appeared
to be an unreliable classiﬁcation.” However, even using our broad
categories, agreement is only 71.9%, and using the authors' ﬁve
group category is 64.1%.
Butler et al. (1987) described a study in New Mexico, USA
involving 627 cases diagnosed in 1970e72. Adequate material was
obtained for 308, with histological type reviewed by two patholo-
gists according to World Health Organization, (1982). The review
transferred 32 cases to AdC and 10 from AdC increasing the per-
centage from 23.4% to 30.5%. They also reviewed 418 slides from
746 cases diagnosed in 1980e81, just before the classiﬁcation was
revised. Numbers of cases transferred into and out of AdC were
similar (29 and 32), the percentage changing from 25.6% to 24.9%.
Wichmann et al. (1990) described a study in Germany involving
139 cases diagnosed in 1984e88 and reviewed according to World
Health Organization, (1981). Review did not materially affect the
AdC percentage, which changed from 19.4% to 18.0%. There were,
however, 30 cases where the review changed the classiﬁcation, 14
affecting AdC.
In a large US case-control study in 1985e88 (Fontham et al.,
1991), the slides were reviewed by one pathologist. This
increased the proportion of AdC from 68.0% to 78.3%, mainly due to
reallocation of LgCC and SqCC. The large proportion of AdCs is
because the study concerned female lifelong nonsmokers.
Campobasso et al. (1993) described a study in Turin, Italy of
cases operated on in 1954e74. The consensus diagnosis of two
observers based on World Health Organization, (1981) was
compared with earlier diagnoses according to WHO 1967
(Kreyberg, 1967a). The authors noted that “When comparing the
ﬁnal typing to the previous typing based on the 1967 WHO clas-
siﬁcation, squamous- and large-cell carcinomas were reduced
respectively by 22% and 33% and AdCs increased by 94% of the
original number”, and that “these changes must be taken into ac-
count when considering epidemiological studies, especially those
aiming at evaluation of the secular trends of lung cancer by cell
type”.
Brownson et al. (1995) described a study in Missouri, USA, in
which, for 482 cases in never and long term ex-smokers the original
classiﬁcation of type was reviewed by three pathologists and a
consensus (or majority) diagnosis reached according to World
Health Organization, (1982). Omitting 14 non-lung cancer cases,
the review increased the proportion of AdC from 62.0% to 66.5%.
Excluding BalC from AdC, the change was from 53.4% to 62.4%.
Caldwell and Berry (1996) reviewed all cases seen at the Royal
London Hospital, UK in 1970, 1980 and 1990 according to World
Health Organization, (1982). Of the 376 tumours, 186 considered
on light microscopy to be poorly differentiated SqCC or AdC, or
Table 1
Comparison of initial and review diagnosis of lung cancer type from 10 studies.





SqCC AdC Other Total (%)
Weiss et al. (1970)
Males
Philadelphia, USA 1951e60 Modiﬁed 1967b SqCC 62 4 8 74 (46.0)
AdC 4 25 3 32 (19.9)
Other 16 2 37 55 (34.2)
Total (%) 82 (50.9) 31 (19.3) 48 (29.8) 161 (100.0)
Yesner et al. (1973)
Both sexes
Connecticut, USA 1953e59 Modiﬁed 1967b SqCCc 142 37 32 211 (47.0)
AdC 4 63 13 80 (17.8)
Other 15 31 112 158 (35.2)
Total (%) 161 (35.9) 131 (29.2) 157 (35.0) 449 (100.0)
Vincent et al. (1977a)
Both sexes
Buffalo, USA 1962e68 Modiﬁed 1967d SqCC 115 15 19 149 (51.6)
AdCe 2 23 8 33 (11.4)
Other 2 14 91 107 (37.0)
Total (%) 119 (41.2) 52 (18.0) 118 (40.8) 289 (100.0)
Greenberg et al. (1984)
Both sexes
Two statesf, USA 1973e76 1967g SqCC 428 29 50 507 (43.0)
AdC 15 118 33 166 (14.1)
Other 118 86 302 506 (42.9)
Total (%) 561 (47.6) 233 (19.8) 385 (32.7) 1179 (100.0)
Butler et al. (1987)
Both sexes
New Mexico, USA 1970e72 1982h SqCCc 63 7 34 104 (33.8)
AdC 2 62 8 72 (23.4)
Other 16 25 91 132 (42.9)
Total (%) 81 (26.3) 94 (30.5) 133 (43.2) 307 (100.0)
1980e81 1982h SqCCc 103 10 34 147 (35.2)
AdC 4 75 28 107 (25.6)
Other 17 19 128 164 (39.2)
Total (%) 124 (29.7) 104 (24.9) 190 (45.5) 418 (100.0)




1984e88 1981j SqCC 43 1 11 55 (39.6)
AdC 5 19 3 27 (19.4)
Other 5 5 47 57 (41.0)
Total (%) 53 (38.1) 25 (18.0) 61 (43.9) 139 (100.0)
Fontham et al. (1991)
Female nonsmokers
Five areask, USA 1985e88 Unstated SqCC 16 6 2 24 (6.7)
AdC 0 237 7 244 (68.0)
Other 4 38 49 91 (25.3)
Total (%) 20 (5.6) 281 (78.3) 58 (16.2) 359 (100.0)
Campobasso et al. (1993)
Both sexes
Turin, Italy 1954e74l 1967g, 1981j SqCC 253 28 67 348 (48.2)
AdC 0 104 6 110 (15.2)
Other 16 81 167 264 (36.6)
Total (%) 269 (37.3) 213 (29.5) 240 (33.2) 722 (100.0)
Brownson et al. (1995)
Female nonsmokersm
Missouri, USA 1986e92 1982h SqCC 24 17 24 65 (13.9)
AdCn 1 256 33 290 (62.0)
Other 2 38 73 113 (24.1)
Total (%) 27 (5.8) 311 (66.5) 130 (27.8) 468 (100.0)
Caldwell and Berry (1996)
Both sexes
London, UK 1970 1982h SqCCo 72 [16] 10 21 103 (63.6)
AdC 0 22 [11] 3 25 (15.4)
Other 0 2 32 [9] 34 (21.0)
Total (%) 72 (44.4) 34 (21.0) 56 (34.6) 162 (100.0)
1980 1982h SqCCo 31 [9] 23 17 71 (64.5)
AdC 0 8 [2] 2 10 (9.1)
Other 1 2 26 [5] 29 (26.4)
Total (%) 32 (29.1) 33 (30.0) 45 (40.9) 110 (100.0)
1990 1982h SqCCo 34 [16] 7 13 54 (51.9)
AdC 0 11 [4] 5 16 (15.4)
Other 0 4 30 [4] 34 (32.7)
Total (%) 34 (32.7) 22 (21.2) 48 (46.2) 104 (100.0)
a Refers to WHO classiﬁcation unless stated.
b Yesner et al., 1965.
c The authors used the term “epidermoid carcinoma”.
d Matthews, 1973.
e Includes 8 cases of BalC originally, and 3 on review.
f New Hampshire and Vermont.
g Kreyberg, 1967a.
h World Health Organization, 1982.
i North Rhine Westphalia and Northern Germany.
j World Health Organization, 1981.
k Atlanta, Houston, Los Angeles, New Orleans, San Francisco Bay.
l Original diagnosis not used, the comparison being between WHO 1967 and 1981 criteria.
m Includes long-term ex-smokers.
n Includes 40 cases of BalC originally, 19 on review.
o Square brackets indicate numbers of cases subjected to immunocytochemical study where diagnosis of lung cancer type was unchanged. It is assumed the diagnosis was
unchanged in those not studied by immunocytochemistry.
P.N. Lee, J.R. Gosney / Regulatory Toxicology and Pharmacology 81 (2016) 322e333 325undifferentiated LgCC, were subjected to immunocytochemical
study to aid classiﬁcation. SqCC was consistently over-diagnosedand AdC consistently under-diagnosed. Overall, the review moved
10 cases from, and 48 into AdC, increasing AdCs from 51 to 89.
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review, but did not present a two-way table. This study (Dale et al.,
1989) was based on 139 Norwegian patients, where the diagnosis in
1971e81 based onWHO 1967 (Kreyberg, 1971), was compared with
that by three pathologists using the 1981 version (World Health
Organization, 1982). This increased AdCs from 32 to 49 and
reduced SqCCs from 81 to 69.
Table 2 summarizes results for AdC from the studies in Table 1
and that where the full two-way table was unavailable (Dale
et al., 1989). Overall, of 1212 originally diagnosed AdCs, the re-
viewers considered the diagnosis was not AdC in 189 (15.6%). In
contrast, of 1564 AdC diagnosed on review, 541 (34.6%) had not
been diagnosed originally. For the 11 studies considered, the review
increased AdCs by 30%. Little or no increase in AdCs was seen in
four datasets, with ratios 0.93, 0.97, 0.97 and 1.07, but increases by
15% or morewere seen in all others, highly signiﬁcant (p < 0.001) in
ﬁve. Though the ratio of reviewed to original cases may depend on
the time from original assessment to review, the sources generally
do not state this. Three studies with ratios about 1 involved a re-
view published shortly after the time period for the cases ended,
while the largest ratios generally involved a longer time period
before review. No clear relationship of the ratio to the classiﬁcation
system used for the review was evident. Overall, the results
strongly suggest changes in classiﬁcation have increased numbers
of reported AdCs.
Changes in classiﬁcation also clearly increased the AdC/SqCC
ratio. Of 14 data sets in Table 2, the ratio was more than doubled in
ﬁve, being as high as 7.32 in the second dataset for Caldwell and
Berry (1996).
Five other studies provide some information, but in an incon-
venient form.
Whitwell (1961) reported a study in Liverpool, UK in which di-
agnoses in 1950e55 were reviewed based on bronchial biopsy
specimens, and by comparison of biopsy with operation specimen
reports. Discrepancies were noted in 64 (8%) of 807 cases. Where
alterations were made in cell type, 18 were for SqCC, 5 for SmCC
(oat cell carcinoma), 41 for LgCC (simplex carcinoma), and none for
AdC.
Ganz et al. (1980) attempted to review the diagnosis of 96 pa-
tients aged up to 40 years seen in Los Angeles, USA from 1956 to 76,
but only 68 could be reviewed. Originally, lung cancer type wasTable 2
Summary of results for adenocarcinoma (including bronchioloalveolar carcinoma).
Source Review criteria Number of reported
Agreed Original o
Weiss et al. (1970) Yesner et al. (1965) 25 7
Yesner et al. (1973) Yesner et al. (1965) 63 17
Vincent et al. (1977a) Matthews (1973) 23 10
Greenberg et al. (1984) Kreyberg (1967a) 118 48
Butler et al. (1987),c World Health Organization (1982) 62 10
75 32
Wichmann et al. (1990) World Health Organization (1981) 19 8
Fontham et al. (1991) Unstated 237 7
Campobasso et al. (1993) World Health Organization (1981) 104 6
Brownson et al. (1995) World Health Organization (1982) 256 34
Caldwell and Berry (1996),d World Health Organization (1982) 22 3
8 2
11 5
Total 10 studies 1023 189
Dale et al., 1989 Kreyberg (1971) e e
Total 11 studies
a Ratio 1 is reviewer total AdC to original total AdC. Signiﬁcance level based on McNe
b Ratio 2 is reviewer ratio of AdC/SqCC divided by corresponding ratio for original dia
c First line is for 1970e72 cases, second for 1980e81 cases.
d First line is for 1970 cases, second for 1980 cases, third for 1990 cases.classiﬁed for 83 patients, with 26 (31.3%) SqCC, 27 (32.5%) AdC, and
30 (36.1%) SmCC or undifferentiated carcinoma. Based on review
using “a modiﬁcation of the World Health Organization (WHO)
system” type was re-classiﬁed for 64 patients, with 6 (9.4%) SqCC,
31 (48.4%) AdC, and 27 (42.2%) SmCC or undifferentiated. These
ﬁndings accord with a large increase in the AdC/SqCC ratio.
Falk et al. (1992) described a study in Louisiana, USA involving
43 cases identiﬁed in 1979e82, 33 of BalC and 10 with other his-
tologies. On review by one pathologist, only 21 BalCs were
conﬁrmed, 7 being subsequently reclassiﬁed as AdC. The authors
also note problems due to insufﬁcient sections and lack of slide
material.
Brewster et al. (1995) assessed data accuracy lung cancer
registration in Scotland, reviewing a random sample of registra-
tions in 1990, 309 with medical records available. There were 2
cases where AdCwas unconﬁrmed, and 7 where AdC not registered
initially were seen on review. Among 298 validated cases of lung
cancer, 34 (11.4%) were classiﬁed as AdC, so presumably there were
29 (9.7%) initially.
Nyberg et al. (1998) described a case-control study in Stock-
holm, Sweden in 1989e1995 involving 124 never smoking cases.
For 96%, a pathologist reviewed the histological and cytological
slides. They noted that the reviewer agreed for 77.5% of the
reviewed slides. Full details were not given, but it was reported the
majority of discrepancies related to transfers in or out of AdC.
Frequencies of AdC were not given.3.4. Time changes in histological type of lung cancer reported using
standard diagnostic criteria
Sixteen studies reviewed time changes in the distribution of
type using standard criteria, reporting results for separate time
periods. This approach avoids bias from changes in tumours clas-
siﬁcation, though not accounting for changes in specimens avail-
able for examination. Table 3 (males), 4 (females) and 5 (sexes
combined) summarize relevant ﬁndings. Six of the studies (Barsky
et al., 1994; Beard et al., 1985; Herman and Crittenden, 1961; O'Neal
et al., 1957; Spain, 1959; Tanaka et al., 1988) covered a period of at
least 30 years. While two studies (Spain, 1959; Vincent et al., 1977a)
only present ﬁndings for AdC, the others allow consideration of
three groups e SqCC, AdC and other. BalC was mostly included incases of AdC
nly Reviewer only Original total Reviewer total Ratio 1a Ratio 2b
6 32 31 0.97 0.87
68 80 131 1.64 (p < 0.001) 2.15
29 33 52 1.58 (p < 0.1) 1.97
115 166 233 1.40 (p < 0.001) 1.27
32 72 94 1.31 1.66
29 107 104 0.97 1.15
6 27 25 0.93 0.96
44 244 281 1.15 (p < 0.001) 1.38
109 110 213 1.94 (p < 0.001) 2.51
55 290 311 1.07 2.58
12 25 34 1.36 1.95
25 10 33 3.30 (p < 0.001) 7.32
11 16 22 1.38 2.18
541 1212 1564 1.29 (p < 0.001) 1.51
e 32 49 1.53 (p < 0.1) 1.80
1244 1613 1.30 (p < 0.001) 1.52
mar test; p  0.1 if not given.
gnosis.
Table 3
Changes over time in the reported distribution of lung cancer type in males.
Study Location Criteria Period Numbers of cases % of total Trend pb
Total SqCCa AdC Other SqCC AdC SqCC AdC
O'Neal et al. (1957) Missouri, USA Kirklin et al. (1955) 1910e29 6 2 1 3 33.3 16.7 NS NS
1930e38 49 19 10 20 38.8 20.4
1940e44 37 8 5 24 21.6 13.5
1945e54 164 52 25 87 31.7 15.2
Spain (1959) New York, USA Seec 1912e21 5 e 3 e e 60.0 NS
1922e31 16 e 4 e e 25.0
1932e41 69 e 19 e e 27.5
1942e46 40 e 9 e e 22.5
1947e56 95 e 20 e e 21.1
Herman and Crittenden (1961) California, USA Herman and Crittenden (1961),d 1927e34 34 16 1 17 47.1 2.9 NS þ
1935e39 81 31 6 44 38.3 7.4
1940e44 143 61 9 73 42.7 6.3
1945e49 152 55 22 75 36.2 14.5
1950e54 185 60 25 100 32.4 13.5
1955e57 134 52 14 68 38.8 10.4
Kreyberg (1952),e 1927e34 35 15 4 16 42.9 11.4 NS þþ
1935e39 81 25 21 35 30.9 25.9
1940e44 142 51 36 55 35.9 25.4
1945e49 158 55 38 65 34.8 24.1
1950e54 196 64 58 74 32.7 29.6
1955e57 147 45 53 49 30.6 36.1
Auerbach et al. (1975) New Jersey, USA Yesner et al. (1965) 1955e57 159 44 48 67 27.7 30.2 (þ) NS
1960e64 170 61 39 70 35.9 22.9
1965e67 195 78 46 71 40.0 23.6
1968e72 138 50 34 54 36.2 24.6
Chan and Maclennan (1977) Hong Kong World Health Organization (1967),f 1960e64 136 45 19 72 33.1 14.0 (þ) NS
1965e68 166 82 22 62 49.4 13.3
1969e72 274 124 49 101 45.3 17.9
Beard et al. (1985) Minnesota, USA World Health Organization (1982) 1935e54 37 13 8 16 35.1 21.6 NS NS
1955e64 75 25 15 35 33.3 20.0
1965e74 131 59 28 44 45.0 21.4
1975e79 75 23 22 30 30.7 29.3
Butler et al. (1987) New Mexico, USA World Health Organization (1982) 1970e72 234 66 61 107 28.2 26.1 NS NS
1980e81 278 94 62 122 33.8 22.3
Tanaka et al. (1988) Tokyo, Japan World Health Organization (1981) 1950e64 59 12 28 19 20.3 47.4 (þ) NS
1965e74 70 16 28 26 22.9 40.0
1975e83 94 30 35 29 31.9 37.2
Wahbah et al. (2007) Texas, USA Beasley et al. (2005),g 1980e83 495 229 134 132 46.3 27.1 e þþþ
1984e87 530 228 153 149 43.0 28.9
1988e91 446 173 162 111 38.8 36.3
1992e95 514 168 189 157 32.7 36.8
1996e99 542 187 191 164 34.5 35.2
2000e03 449 160 166 123 35.6 37.0
a Includes lung cancers described as epidermoid.
b p values coded as follows: þþþ, — p < 0.001; þþ, – p < 0.01; þ, p < 0.05; (þ), (-) p < 0.1; NS p  0.1.
c “Any carcinoma in which there was deﬁnite gland formation was classiﬁed as AdC. This included mixed patterns that contained acini”.
d Modiﬁcation of criteria described by Liebow (1952). BalCs not classiﬁed under AdCs.
e Also described by World Health Organization (1958). BalCs not classiﬁed under AdCs.
f Includes superﬁcial squamous tumour (Type VIII) in epidermoid carcinoma (Type I).
g Also described by Travis et al. (2004). In addition “new or improved methods of diagnosis (special studies, immunohistochemical studies) were used to further delineate
those specimens that were diagnosed previously as undifferentiated or poorly differentiated carcinomas”. “Other” only includes large and small cell lung cancers.
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Crittenden, 1961; Valaitis et al., 1981), BalC was included in the
“other” group, while in two (Auerbach and Garﬁnkel, 1991; Barsky
et al., 1994), separate results were provided for BalC, allowing
assessment of trends for alternative AdC deﬁnitions, and for BalC
itself. We describe the studies brieﬂy, and then draw overall
conclusions.
O'Neal et al. (1957) described a study in St. Louis, USA of autopsy
records including microsections, from deaths in 1910e54. There
were 256 male and 45 female cases, with no clear time change in
either sex in the reported proportion of AdC.
The similar study of Spain (1959) in New York, USA included 225
male and 54 female autopsy cases in 1912e56. Again, there was no
evident time change in the reported proportion of AdC.
Herman and Crittenden (1961) reviewed 956 autopsy cases in
California, USA in 1927e57. “The neoplasms were reclassiﬁedaccording to two criteria: 1) a modiﬁcation of Liebow's method in
which hematoxylin-and-eosin-stained sections were used; 2) that
of the World Health Organization in which, in addition, sections
specially stained to demonstrate mucin and keratin were used.”
There was a clear increase in the reported proportion of AdC over
time in both sexes, regardless of criterion used, though proportions
varied markedly by reclassiﬁcation method.
Kennedy (1973) reviewed 168 female cases in Shefﬁeld, UK in
1955e71. There was a small rise in the reported proportion of SqCC
and an irregular ﬂuctuation in the proportion of AdC. The authors
noted “no statistically signiﬁcant change over the period studied.”
An autopsy study in New Jersey, USA (Auerbach et al., 1975)
assessed the type distribution in men in 1955e72. The authors
noted that “the pattern appeared to indicate a decrease in the
proportion of small cell carcinoma…. an increase in large cell un-
differentiated …. ”, though “no pattern appears for epidermoid
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differences “are rather small and are not statistically signiﬁcant…. ”
Beamis et al. (1975) reviewed 201 cases in women in New En-
gland, USA in 1957e72, noting “no statistically signiﬁcant
change.… over the years studied”, although there was “a marked
rise in the total number of women seen with carcinoma of the lung
over the study period.” Ten years later, the study was extended to
include two additional 4-year periods (Andrews et al., 1985).
Although they still noted “no signiﬁcant changes occurred over the
years”, some tendency is evident for the reported proportion of AdC
to increase in later periods (trend p < 0.01).
A study in Hong Kong (Chan andMaclennan,1977) reviewed 576
male and 277 female cases diagnosed in 1960e1972. There was
some rise in males in the reported proportion of epidermoid car-
cinoma, though evident only in bronchial biopsies, and not in lung
biopsies, resections, or autopsies. There was no corresponding rise
in females. Slight rises in the reported proportions of AdC were not
statistically signiﬁcant.
In the Buffalo study described earlier (Vincent et al., 1977a), 289
cases diagnosed in 1962e68 and 264 in 1973e75 were reviewed.
The authors noted “results [not given by sex] showed an increase in
diagnosis of AdC from 17% of cases diagnosed in the 1962-68 group
to 32.6% in the 1973-75 group”. Lung tumours were typed using a
classiﬁcation (Matthews, 1973), noted “very similar” to WHO 1967
(Kreyberg, 1967b).
Valaitis et al. (1981) reviewed 219 cases in Chicago, USA. 102
were diagnosed in 1963e67 and 117 in 1974e76. For sexes com-
bined, the reported proportion of AdC increased between the ﬁrst
period (33%) and second (44%), an increase not statistically signif-
icant at p < 0.05, though the authors claimed it was. Available re-
sults by sex do not allow inclusion in Tables 3 and 4.
Beard et al. (1985) described a review by one pathologist using
standard criteria, of cases in Minnesota, USA over 1935e79. There
were no clear changes in the reported relative frequency of AdC and
SqCC. Beard et al. (1988) extended the results to 1984. Results by
type were not tabulated, but it was noted “the proportional dis-
tribution of cell types changed little with time. For example AdC
accounted for 37%, 28%, 30%, and 38%, respectively, of all histolog-
ically conﬁrmed bronchogenic carcinomas in four time periods,
1935e54, 1955e64, 1965e74, and 1975e84”. They also noted no
signiﬁcant difference in the estimated annual percentage increase
by cell type.
In the New Mexico study described earlier (Butler et al., 1987)
the distribution of type by sex was reported for 1970e72 and
1980e81. There was no increase in the reported proportion of AdC,
with a small decline in males, from 26.1% to 22.3%, and a larger,
signiﬁcant (p < 0.05), decline in females, from 47.1% to 30.0%.
Tanaka et al. (1988) reviewed 282 autopsied cases in Tokyo in
1950e83. A trend towards a reducing proportion of AdC in each sex
over the periods studied was noted to be signiﬁcant (p < 0.05) for
sexes combined.
Auerbach and Garﬁnkel (1991) reviewed 505 autopsied cases
seen in various US hospitals mainly in 1973e89, with some diag-
nosed earlier. In the 497 males there was no trend in the reported
proportion of AdC, but an increasing trend for BalC.
Barsky et al. (1994) reviewed 1527 cases (1125 in males) in Los
Angeles, USA in 1955e90. A ﬁgure gave numbers of cases by pe-
riods for sexes combined, the data in Table 5 being estimated from
this. There was a striking increase in reported numbers of BalC,
with less than 5 in each of 1955e60, 1961e65 and 1966e70, rising
steadily to over 60 by 1986e90. The authors, noted that when cases
of BalC expressed as a percentage of total lung cancers were
analyzed in successive 5-year periods from 1955 to 1990, occur-
rence “rose from less than 5%e24.0% (p < 0.001), whereas the
occurrence of AdC overall rose from 14.6% to 46.5% (p < 0.001)” andthat the rise in BalC “accounted for most of the overall increase in
AdC.” There was little change in the proportion of non-BalC AdC
over most of the period. The authors also noted that, among BalC
cases, approximately 30% never smoked, with the distribution
“relatively constant” over the study period. This suggests BalC
incidence in never smokers also increased sharply. The authors
suggested a possible viral origin for BalC, noting its histological
similarity to “jaagsiekte” or sheep pulmonic adenomatosis, an
endemic disease of sheep. Although not attempting to review evi-
dence here, it is interesting that earlier Dungal (1950) noted that
though jaagsiekte was then widespread in sheep in Iceland he
never found human lungs resembling the diseased lungs in sheep.
In the London Hospital study described earlier (Caldwell and
Berry, 1996), the type distribution was presented for 1970, 1980
and 1990 based on 376 cases, 288 in males. There was no consistent
increase in the reported proportion of AdC for the sexes combined.
Wahbah et al. (2007) reviewed 4439 cases from Texas, USA in
1980e2003. We summarized data presented in single years by
four-year period. In men, the reported proportion of AdC has
increased, while that for SqCC has decreased. The main changes
apparently occurred by about 1990, with little subsequent shift in
distribution. The rise in AdC proportion up to about 1990 seems
more marked in females. The authors note that AdC “has become
the most frequent histologic type in men and women”.
Of the 16 studies described, three (Herman and Crittenden,
1961; O'Neal et al., 1957; Spain, 1959) studied US trends from just
before World War I up to about 10 years after World War II using
autopsy material. None found any signiﬁcant change in the re-
ported proportion of SqCC. Among two studies including BalC
amongst AdC, O'Neal et al. (1957) found no signiﬁcant trend in the
reported proportion of AdC in either sex, while Spain (1959) found
no trend in males and a signiﬁcant (p < 0.01) decline in females. In
contrast, in the study excluding BalC from AdC (Herman and
Crittenden, 1961), there was evidence of an increasing trend in
both sexes, most clearly evident when cases were classiﬁed ac-
cording to Kreyberg (1952) than to the author's modiﬁed Liebow
criteria. A further non-autopsy US study (Beard et al., 1985)
covering 1935e79 found no signiﬁcant trends in either sex.
Other studies concern the second half of the 20th century, only
three (Auerbach and Garﬁnkel, 1991; Auerbach et al., 1975; Tanaka
et al., 1988) restricted to autopsy cases. The evidence relates to four
countries. Studies in Japan, the UK and Hong Kong included BalC
among AdC, while US studies varied in their approach.
Of the two UK studies, neither Kennedy (1973), considering fe-
males in 1955e71, nor Caldwell and Berry (1996), considering sexes
combined for 1970, 1980 and 1990, found any signiﬁcant trend in
the reported proportion of AdC, though a declining trend (p < 0.05)
in the proportion of SqCC was seen in the latter study.
The study of Chan and Maclennan (1977) in Hong Kong, which
considered 1960e72, showed no signiﬁcant (p < 0.05) trends in
either sex in the reported proportion of AdC or SqCC. The autopsy
study of Tanaka et al. (1988) in Japan, which considered 1956e83,
reported some evidence, not signiﬁcant (p < 0.05), of an increase in
the proportion of SqCC in both sexes. A declining trend in the
proportion of AdC was signiﬁcant (p < 0.05) in females, but not
males.
Eight US studies considered trends over periods starting, at the
earliest, in 1955. Four included BalC among AdC. Vincent et al.
(1977a) reported a clear (<0.001) increase in the proportion of
AdC over 1967e75, but did not report SqCC results. A signiﬁcant
(p < 0.001) positive trend in the proportion of AdC was also re-
ported in both sexes by Wahbah et al. (2007), though only evident
from 1980 to about 1990, with no further change up to 2003. A
signiﬁcant (p < 0.001) decline (again concentrated in the earlier
period) was also reported for SqCC, though only in males. In
Table 4
Changes over time in the reported distribution of lung cancer type in females.
Study Location Criteria Period Numbers of cases % of total Trend pb
Total SqCCa AdC Other SqCC AdC SqCC AdC
O'Neal et al. (1957) Missouri, USA Kirklin et al. (1955) 1910e29 5 0 4 1 0.0 80.0 NS NS
1930e39 8 3 4 1 37.5 50.0
1940e44 7 1 1 5 14.3 14.3
1945e54 25 2 12 11 8.0 48.0
Spain (1959) New York, USA See c 1912e21 1 e 1 e e 100.0 e
1922e31 5 e 5 e e 100.0
1932e41 14 e 9 e e 64.3
1942e46 9 e 5 e e 55.6
1947e54 25 e 10 e e 40.0
Herman and Crittenden (1961) California, USA Herman and Crittenden (1961),d 1927e44 54 19 6 29 35.2 11.1 (þ) NS
1945e57 88 19 18 51 21.6 20.5
Kreyberg (1952),e 1927e44 52 10 18 24 19.2 34.6 NS þ
1945e57 91 17 49 25 18.7 53.8
Kennedy (1973) Shefﬁeld, UK Whitwell (1961) 1955e59 23 4 2 17 17.4 8.7 NS NS
1960e63 38 7 11 20 18.4 28.9
1964e67 49 16 9 24 32.7 18.4
1968e71 58 16 14 28 27.6 24.1
Andrews et al. (1985) New England, USA See f 1957e60 34 8 12 14 23.5 35.3 (þ) þþ
1961e64 36 2 9 25 5.6 25.0
1965e68 65 12 19 34 18.5 29.2
1969e72 66 10 22 34 15.2 33.3
1973e76 87 16 37 34 18.4 42.5
1977e80 106 29 52 25 27.4 49.1
Chan and Maclennan (1977) Hong Kong World Health Organization (1967),g 1960e64 86 14 25 47 16.3 29.1 NS NS
1965e68 97 30 36 31 30.9 37.1
1969e72 94 19 34 41 20.2 36.2
Beard et al. (1985) Minnesota, USA World Health Organization (1982) 1935e64 26 1 18 7 3.8 69.2 (þ) NS
1965e74 38 4 22 12 10.5 57.9
1975e79 32 7 17 8 21.9 53.1
Butler et al. (1987) New Mexico, USA World Health Organization (1982) 1970e72 68 14 32 22 20.6 47.1 NS e
1980e81 140 30 42 68 21.4 30.0
Tanaka et al. (1988) Tokyo, Japan World Health Organization (1981) 1950e64 16 1 15 0 6.3 93.8 NS e
1965e74 19 4 12 3 21.1 63.2
1975e83 24 5 12 7 20.8 50.0
Wahbah et al. (2007) Texas, USA Beasley et al. (2005),h 1980e83 257 70 85 102 27.2 33.1 NS þþþ
1984e87 267 78 87 102 29.2 32.6
1988e91 179 42 85 52 23.5 47.5
1992e95 272 77 110 85 28.3 40.4
1996e99 242 59 100 83 24.4 41.3
2000e03 244 53 114 77 21.7 46.7
a Includes lung cancers described as epidermoid.
b p values coded as: þþþ,— p < 0.001; þþ,– p < 0.01; þ, p < 0.05; (þ), () p < 0.1; NS p  0.1.
c “Any carcinoma in which there was deﬁnite gland formation was classiﬁed as AdC. This included mixed patterns that contained acini”.
d Modiﬁcation of criteria described by Liebow (1952). BalCs not classiﬁed under AdCs.
e Also described by World Health Organization (1958). BalCs not classiﬁed under AdCs.
f According to Beamis et al. (1975), who reported results for the ﬁrst four time periods, the classiﬁcation “Parallels closely that established by theWorld Health Organization
in 1967”. However, the deﬁnition of AdC appeared to exclude BalC.
g Includes superﬁcial squamous tumour (Type VIII) in epidermoid carcinoma (Type I).
h Also described by Travis et al. (2004). In addition “new or improved methods of diagnosis (special studies, immunohistochemical studies) were used to further delineate
those specimens that were diagnosed previously as undifferentiated or poorly differentiated carcinomas”. “Other” only includes large and small cell lung cancers.
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clines in the proportion of SqCC were reported by Auerbach et al.
(1975) over the period 1955e72 or by Butler et al. (1987) over the
period 1970e1981, the only signiﬁcant trend seen being a decline in
the reported proportion of AdC in females in the second of these
studies.
Two studies separated BalC from AdC but did not present results
for BalC. Andrews et al. (1985), studying females over 1957e80,
found evidence of a rise in the proportion of AdC (trend p < 0.01),
but this was only seen in the last 10 years or so. A rise was also seen
by Valaitis et al. (1981) over 1963e76, but this was not signiﬁcant
(at p < 0.05). Neither study found any signiﬁcant trend in the
proportion of SqCC.
The ﬁnal two studies presented separate results for BalC and
other types of AdC. The autopsy study of Auerbach and Garﬁnkel
(1991) reported a signiﬁcant (p < 0.05) increasing trend for sexes
combined over 1973e89 for the proportion of BalC, and of AdCincluding BalC, but not for SqCC or AdC excluding BalC. Barsky et al.
(1994), presenting data for sexes combined for 1955e1990, re-
ported a highly signiﬁcant (p < 0.001) positive trend in proportions
for BalC and for AdC including BalC, and a negative trend for SqCC,
but no clear trend for AdC excluding BalC. These trends are
particularly striking, with the SqCC proportion massively exceeding
that for BalC in 1955e60 (53.7% vs 2.4%) but being similar in
1986e1990 (21.9% vs 24.0%). The author noted many BalC cases
never smoked and that the smoking distribution in cases remained
relatively constant over the period, suggesting a true rise in BalC in
the USA, affecting nonsmokers and smokers alike, with no clear
increase in other forms of AdC. The US Surgeon General (2001)
refers to increases in BalC in these two studies, but notes this was
not seen in the population study of Zheng et al. (1994). This study,
concerning trends in Connecticut in 1960e88, was not considered
above, as the available material was not classiﬁed for type using
standard criteria. Records were recoded in 1977 to the ICD-
Table 5
Changes over time in the reported distribution of lung cancer type in sexes combined.
Study Location Criteria Period Numbers of cases % of total Trend pb
Total SqCC AdCa Other SqCC AdC SqCC AdC
Vincent et al. (1977a) Buffalo, USA Matthews (1973) 1962e68 289 e 49 e e 17.0 þþþ
1973e75 264 e 86 e e 32.6
Valaitis et al. (1981) Chicago, USA Kreyberg (1967b),c 1963e67 102 26 34 42 25.5 33.3 NS (þ)
1974e76 117 30 52 35 25.6 44.4
Auerbach and Garﬁnkel (1991) New Jersey, USAd Seee 1968e77f 88 36 17 (8) 35 40.9 19.3 (9.1) NS þg
1978e81 182 67 45 (23) 70 36.8 24.7 (12.7)
1982e85 112 38 37 (18) 37 33.9 33.0 (16.1)
1986e89 123 53 39 (25) 31 43.1 31.7 (20.3)
Barsky et al. (1994),h California, USA World Health Organization (1981) 1955e60 41 22 6 (1) 13 53.7 14.6 (2.4) e þþþi
1961e65 131 51 28 (2) 52 38.9 21.4 (1.5)
1966e70 107 37 28 (5) 42 34.6 26.2 (4.7)
1971e75 245 88 77 (20) 80 35.9 31.4 (8.2)
1976e80 326 99 127 (39) 100 30.4 39.0 (12.0)
1981e85 399 135 154 (49) 110 33.8 38.6 (12.3)
1986e90 279 61 132 (67) 86 21.9 47.3 (24.0)
Caldwell and Berry (1996) London, UK World Health Organization (1982) 1970 162 72 34 56 44.4 21.0 e NS
1980 110 32 33 45 29.1 30.0
1990 104 34 22 48 32.7 21.2
a Bracketed numbers are BalCs.
b p values coded as: þþþ,— p < 0.001; þþ,– p < 0.01; þ, p < 0.05; (þ), () p < 0.1; NS p  0.1.
c Modiﬁed. Deﬁnition of AdC excluded BalC. As separate results not provided, these cases are included in “Other”.
d “And from a number of other hospitals in the United States”.
e It is stated that “diagnoses were made according to the criteria established in the World Health Organization classiﬁcation”, not further deﬁned.
f Most cases were collected between 1973 and 1989 though some were diagnosed in the late 1960s.
g Trend p þ for BalC, NS for AdC omitting BalC.
h Numbers and percentages estimated from graph.
i Trend p þþþ for BalC, (þ) for AdC omitting BalC.
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previously been used, and it seems unlikely true comparability can
be obtained simply by recoding.
The inconsistent nature of the reported trends in the proportion
of AdC within study are further illustrated in Fig. 1 (males), Fig. 2
(females) and Fig. 3 (sexes combined). Overall, of the 16 studies
considered, seven show no signiﬁcant (p < 0.05) trend, three aFig. 1. Variation in the reported percentage of adenocarcinoma in males by time period
Percentages based on 10 cases are omitted. For the California study, the data are based on
considered over the period.signiﬁcant declining trend (in females only), and six evidence of an
increase, possibly due to a true rise in BalC .
4. Discussion
We have shown that there are considerable difﬁculties in
accurately and consistently classifying histological type of lungbased on nine studies using consistent diagnostic criteria. Based on data in Table 3.
the Kreyberg criteria. Symbols in plots are in four sizes, with size based on total cases
Fig. 2. Variation in the reported percentage of adenocarcinoma in females by time period based on eight studies using consistent diagnostic criteria. Based on data in Table 4.
Percentages based on 10 cases are omitted. For the California study, the data are based on the Kreyberg criteria. Symbols in plots are in four sizes, with size based on total cases
considered over the period.
Fig. 3. Variation in the reported percentage of adenocarcinoma in sexes combined by time period based on ﬁve studies using consistent diagnostic criteria. Based on data in Table 5.
Symbols in the plots are in four sizes, with size based on total cases considered over the period.
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in the classiﬁcation schemes used. That these have led to some
increase in the reported AdC/SqCC rates is clear not only from the
changes made to the schemes, but also from our analyses in section
3.3 based on studies in which earlier diagnoses of histological type
have been re-evaluated using later classiﬁcation schemes.
In an attempt to determine the extent to which a real change
over time in the AdC/SqCC ratio has occurred, we presented evi-
dence in section 3.4 based on 16 studies which used consistentdiagnostic criteria over a long period of time, six of which consid-
ered at least a 30 year period. The results here were rather con-
ﬂicting, with three showing a declining trend in the proportion of
AdC, seven no trend, and six some increase, with some studies
showing that BalC, but not other AdC subtypes had increased.
While our ﬁndings suggest that at least part of the observed rise
in the AdC/SqCC ratio is due to changes in diagnosis, and do not
very clearly show that there has been any true rise in the ratio, the
US Surgeon General (2014) reaches a very different conclusion. This
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changing diagnostic practices”, citing Charloux et al. (1997) as
support, and claims that the increase “results from changes in the
design and composition of cigarettes since the 1950s” and “is
conﬁned to smokers, because neither the overall risk of lung cancer
nor the risk of adenocarcinoma has changed over time among
never smokers”.
While detailed analysis of their claims is beyond the scope of
this review, we note a number of ﬁndings apparently in conﬂict
with their view. First, Charloux et al. (1997) did not actually suggest
diagnostic changes were unimportant, rather noting that “changes
in classiﬁcation and in pathological techniques account for some of
this increase”, and that the extent to which differences over time
and between continent in the relative frequency of AdC are due to
diagnostic differences “remains unknown”.
Second, Chen et al. (2007) showed the increase in low tar
(<15 mg) ﬁltered cigarette consumption (starting after 1970) did
not precede the observed increase in AdC rates and the AdC/SqCC
ratio.
Third, the epidemiological evidence clearly shows that switch-
ing from high tar plain cigarettes to reduced tar ﬁlter cigarettes is
not associated with any increase in AdC risk (Brooks et al., 2005;
Lee, 2001; Lee et al., 2012; Lee and Sanders, 2004; Marugame
et al., 2004; Papadopoulos et al., 2011), though a small reduction
in SqCC risk will have somewhat affected the AdC/SqCC ratio.
Fourth, the rise is certainly not restricted to smokers. This is
clear both from a meta-analysis (Lee and Forey, 2013) which esti-
mated ratios among never smokers indirectly by combining data
from national rates and epidemiological studies, and also from a
study based on 157 publications (Lee et al., 2016a) of time trends in
the relative distribution of lung cancer type in never smokers.5. Conclusions
While the main four lung cancer types have long remained the
same (though sometimes named differently), there are differences
in how certain tumour types are ascribed to these groups. Notably,
one of the four classes of LgCC in the WHO 1967 classiﬁcation was
moved to AdC in the WHO 1981 classiﬁcation.
There are considerable problems in practice in determining
histological type, with substantial disagreements between pathol-
ogists considering the same cases using the same classiﬁcation
criteria. Often, evidence of more than one type is present, with the
relative frequency of histological types depending on the source of
the specimens examined. Advances in diagnostic techniques have
lessened but not eliminated these difﬁculties.
Combined evidence from 11 studies where a pathologist, or
panel of pathologists, reviewed the diagnosis of histological type
made some years earlier, strongly suggest that the changes in
classiﬁcation have increased the number of reported AdC. In the
combined evidence, reallocation of type to AdC was about three
times more common than reallocation from AdC, with reviews
increasing numbers of AdC by an estimated 30% (p < 0.001).
Evidence from 16 studies examining time trends in the pro-
portion of AdC using standard diagnostic criteria, six considering a
period of at least 30 years, did not ﬁnd consistent evidence of any
increase. Where an increase was seen, it may be due to an increase
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